Murdoch University joined global energy producer Chevron for the official launch of the Harry Butler Institute, set to shape the next generation of leaders in conservation and environmental management. [ + ]

Digital health company Adherium is celebrating a significant milestone, having recently manufactured and sold its 100,000th Smartinhaler. [ + ]

Researchers have developed a way to modify the atomic structure of iron to create a metal that can strip impurities from water in just a few minutes. [ + ]

UK scientists have developed a method to 3D print stem cells to form complex living 3D structures — a breakthrough that could potentially revolutionise regenerative medicine. [ + ]

Scientists have shown how a new approach to genetic analysis could greatly improve diagnostic rates for children with often fatal mitochondrial diseases. [ + ]

According to Spanish and US scientists, stem cells continue to show rhythmic activity during ageing but reprogram their circadian functions. [ + ]

LBT Innovations has been awarded the 2017 SA Science Excellence Award for Excellence in Research Collaboration. [ + ]

Newly developed methods to produce and analyse genetic mosaics are expected to allow researchers to induce multispectral genetic mosaics in vertebrate models such as mice and zebrafish. [ + ]

Biomedical research in Australia faces a number of challenges. Real funding for research has been falling over time. And a cascade of issues confront the community. [ + ]

Scientists have identified a first-in-class molecule that shuts down estrogen-sensitive breast cancer. [ + ]

An international research team is studying various types of lizard venom as possible treatments for blood-clotting diseases. [ + ]

Chinese researchers have engineered bendable batteries, suitable for implantation in the human body, which can run on body-inspired liquids such as a normal IV saline solution and a cell-culture medium. [ + ]

Industry group Life Sciences Queensland has appointed Professor Peter Andrews as its new chairman. [ + ]

LBT Innovations, an Australian-listed medical technology company, has signed an agreement with Central Adelaide Local Health Network (CALHN) Vascular and Endovascular Services to use LBT's WoundVue prototype device in a clinical trial. [ + ]

Starpharma has announced that its two phase 3 trials of VivaGel BV for prevention of recurrent bacterial vaginosis (rBV) achieved their primary objective, demonstrating statistically significant superiority compared to placebo in preventing rBV based on topline data. [ + ]